Telehealth

HIMS | May, 2026 | The time to go long has come - Timeframe: Weekly - Trade type: Buy stop order - Price: 26.64 - Take Profit: Open - Stop Loss: 23.36 (-12.30 %) Idea: Long on a breakout above last week's high — bullish momentum continuation. Entry: Buy stop above last week’s high. Stop-loss: Below the low of the same candle. If the weekly candle closes below this level, the trade is invalidated. Take Profit: Trailing stop following the lows of new weekly candles. 👉 Pionex | 200+ U.S. stock tokens | xStocks Feel free to like and share yo

Is Hims & Hers Disrupting Medicine or Chasing a Bubble?Hims & Hers Health sits at the intersection of consumer technology and clinical care. The stock recently hit fresh 2026 highs. Canaccord Genuity boosted its price target to $40. Meanwhile, a massive $400 million JPMorgan facility unlocks unparalleled corporate liquidity. This digital platform faces both immense market enthusiasm and deep regulatory scrutiny. Telehealth Borders and Geostrategy Telehealth borders are expanding beyond domestic markets. The company actively diversifies its geogra

by TradeThePool

Hims & Hers: Brief Pullback Hims & Hers shares have pulled back to the $30 level recently but then regained momentum and briefly climbed above $35. Our primary outlook calls for HIMS to continue its upward move. Once this rally is complete, we expect renewed selling pressure. There is also a chance the stock could soon face selling pressure again and drop below support at $21.53. If that happens, we’ll expect a reversal above $13.74 (probability: 20%).

$HIMS Legal Overhang Gone. Buy the Dip!Here's the full TradingView idea: 📊 HIMS Three months ago Hims and Hers had a $72.98 stock price, a booming GLP-1 weight loss business, and a growth trajectory that had the market pricing in a dominant telehealth future. Then Novo Nordisk filed a patent infringement lawsuit over Hims' compounded semaglutide products, the FDA cracked down on compounders, and the stock collapsed 62% from its 52-week high. The legal overhang became the single biggest weight on the stock. Investors did not kno

by ConnectmyCurrency

Hims & Hers: Scaling the Global Tech-Health Frontier Hims & Hers Health Inc. (HIMS) delivered a powerful performance in Q4 2025. The company achieved record revenue growth and beat earnings expectations. Strong subscriber expansion drove these results. However, a recent SEC investigation into "copycat" GLP-1 drugs sparked temporary market volatility. Investors are now weighing these regulatory hurdles against the firm's massive global scaling efforts. High-Tech Infrastructure and Patent Strategy Technology serves as the backbone of the Hims &

by TradeThePool

Hims & Hers Health (HIMS) Analysis Hims & Hers Health NYSE:HIMS is a leading telehealth platform delivering personalized care in sexual health, hair loss, dermatology, mental health, and weight loss. Growth Drivers: Weight Loss Service Momentum ⚡ Q1 2025 launch of a GLP-1 prescription program with coaching & diagnostics has unlocked a major new revenue stream. Strong adoption is fueling accelerated growth. Subscriber & Revenue Growth 📊 Q2 2025 subscribers surged 31–38% YoY to 2.4M. Monthly revenue per subscriber jumped 3

by Richtv_official

GoodRX | GDRX | Long at $5.00 GoodRX NASDAQ:GDRX . Going long at $5.00. Pros: Revenue is growing and is expected to reach almost $1 billion by 2027 Debt-to-equity = 0.71x (low) Monthly active users continue to increase (+7% during Q3 of 2024) From a technical analysis perspective, the downward trend is starting to reverse, and the price has connected with my historical simple moving average (likely leading to a price increase) Cons: Not yet profitable A lot of market competition Insiders exercisin

by WorthlessViews

HIMS & HERS Weekly Projection Good evening traders. Waiting on 1st reactionary zone to be tested at the $5.55'ish area based off the weekly chart. After a long bullish move up for several weeks, this is considerably a healthy pullback. On the monthly time frame, however, there is an OB VOID taking HIMS all the way back down to the mid $4's. Considering DJI and SPX have now turned into huge sellers, HIMS has held rather nicely on numerous occasions. Only time will tell. Overall, waiting to average down if and when the mar

by DualScope_Strategies

$TDOC is going to continue its run bottom was in The recent earnings reports can act as pivotal for TDOC and it can continue to rise. First target is $161

by alphainvestorsignals

TLMD - CHANNEL BOTTOM + FALLING WEDGE = BOOM GOES THE DYNAMITE All, This is a crazy crazy setup. WW here for sure. Needs to hold this bottom. Easily worth taking a long here stop loss or not. Id probably not take a stop loss because sooooo many times it dips below all time low and support bottom falls 5-10% then moons. Happens literally all the time. I know not a high volume stock, but if this is right you can long hold for at least 20-40% gain if not more. MUST hold support and/or small dip under otherwise invalidated. HOWEVER following the falling wed

Teladoc Trade [TDOC]A staple of Cathie Wood's ARKK Invest fund, Teladoc looks to be winding up for a big move in the coming days after breaking the resistance of a supply line that has kept TDOC stagnant since the peak of its small rally in June. Now we find it at a key support level just outside of the trendline and finding support on our 21 MA as well. I am long on TDOC with a stop loss at $149.99. At this point, if the green horizontal line of support would be broken, the next level we want to look at for a long

CloudMD $DOC.V - Months of selling and consolidation done?CloudMD has been under selling pressure for months now. Today it closed its Vision Pros Acquisition and is expected to close its largest acquisition - Oncidium this month as well. The company can boast a 125-130mil revenue run rate. Vision Pros adds 22 mil in rev and 10% EBITDA margins to the bottom line for CloudMD. I have a position in this company. It has not been an easy 3-4 months. The rest of the week will prove out if this was a one and done green day yesterday or if buyers are serious

by LeBelleChart

ISWH Looks like leading diagonal forming here. would expect a strong bounce off .32c if this chart is correct and we get 1 more dip. Will be going live in the group and reviewing this chart tonight.

ISWH Loaded up here on the dip to .40c and still holding my original position.

Teladoc Health Ready For A Rally! 🩺TDOC had a massive $133 correction since February 16th. They reported an earnings of -$3.07 which missed estimates of $0.24. Big miss on their earnings accompanied with a correction in the overall market resulted in price landing below $200. The past 4 days TDOC reached a low of $174 and today managed to test the $200 support but failed to get above. I have entered 4/16 $220 calls at close today avg $ of $7.15. Will look to add more TDOC swings on continued show of strength. Over $200/202 TDOC

Amwell, why would it fall more?More than 50% below the January peak. RSI, Stochastic and Williams Oscillator at the oversold point. With the potential to return to $30 in mid-April (almost 40% profit at the current price). Belonging to a growing sector. NYSE:AMWL

by amateur_trad3r

TDOC - Long Teledoc Health (TDOC) is trading inside of a rising wedge that we believe will break to the upside. The green upward trend-line is the target. Our two highly probable scenarios are outlined on the chart. A rise in volume should push the stock above the cyan resistance line. A backtest after the breakout would be a great time to accumulate. - HH

$TDOC back to 250+ in 2021 $TDOC back to 250+ in 2021

by ridethemwaves

ISWH 4H 50 ema acting as strong support. Send it.

TDOC bullish A close above the orange line could push TDOC to $400. *Just free advice, not financial advice. We love to share what we do. - HH

BREAKOUT ALERT!This chart is ready for breakout! the stock is ISWH. they are in to bitcoin mining, telehealth and renewable energy. has a decent share structure. On technicals, this is clearly oversold as evidenced by the stoch rsi and macd; it also held the support really well (red line). This area is where i would scale in, and a break of that 0.26 is my bullish confirmation. As far as Eliot Waves, I strongly think it's setting up for the wave 3. a good catalyst could break that 0.45 resistance and with t

NPTH.V - Biomed/telehealth stock trading below 1x revenues NPTH is significantly undervalued compared to peers: - $33M mkt cap with $50M revenue in 2019 - < 1 EV/sales vs 18.24x industry avg - Recent $12M financing at .90 - Insider options at .87 + open market buys - In major historical support zone

by agstockpicks

Unheard gross margins of 95% and a $800B TAM : $GDRX GoodRx is a free-to-use service that allows Americans to find the lowest-cost prescription drugs in their area. The company makes money by receiving a commission for every prescription order filled via its coupons, which are accepted by nearly all 70,000 pharmacies across the country. -Most Downloaded medical app in US with 4.8/5 rating(700,000+ reviews) -Partnership with Kroger -Competing with TDOC with the launch of HeyDoctor - Rising prices of pharmaceuticals and their mission is to lower th

AMWL: upgrades +26% upside American Well Corp is telehealth. Today they were blasted with upgrades/coverage from 7 different firms, ranging in price target from $29-$44. I personally think that the pandemic has already created the environment for people to steadily transition from face/face interactions when it comes to routine chores.